Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) effects on perception of illusions, schizotypy and cognition in healthy volunteers
This study isn't recruiting yet.
In Australia
Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study isn't recruiting yet.
In AustraliaTissue Levels of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) and Effects on Perception and Personality in healthy volunteers
This study isn't recruiting yet.
In AustraliaThis study isn't recruiting yet.
In AustraliaFeasibility of an Individual Placement and Support (IPS) prototype developed by Waitemata District Health Board (DHB) for people aged 18-35 with severe mental health conditions
This study isn't recruiting yet.
In New ZealandNavigating the Longitudinal Effects of Early Treatment Strategies and Relapse on Clinical, Cognitive, and Functional Outcomes: A 20-Year Follow-up of First Episode Psychosis
Longitudinal Follow-up of Psychiatric Symptoms and Functioning in Young Adults With Autism.
Glutamatergic Mechanisms: Aim2
Read the official source — NCT05401227Glutamatergic Mechanisms of Psychosis and Target Engagement: Aim2
Pilot and Descriptive Study of the Effects of Setting up Computer-assisted Music (CAM) Remediation Groups on the Cognitive Functioning of Young Patients With a First Episode Psychosis (PEP)
Read the official source — NCT05880719Pilot and Descriptive Study of the Effects of the Implementation of Computer Assisted Music Remediation Groups on the Cognitive Functioning of Young Patients Presenting a First Episode Psychosis
Adapting the Social Cognition and Interaction Training (SCIT) for Early Intervention Psychosis. A Preliminary Qualitative Study.
This study isn't recruiting yet.
Location not clearly listedTalking About Cannabis: Developing an Intervention for Family Members of Young Adults With FEP to Support Reduced Cannabis Use
This study isn't recruiting yet.
In SeattleA Multicentre, 8-week, Single-arm, Open-label, Pragmatic Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adult Subjects With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic (Aripiprazole, Olanzapine, Quetiapine, or Risperidone)
This study has finished and is no longer accepting participants.
Multiple locations, including ChertseyWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.